Charmacy Pharmaceutical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	753.6	563.15	634.2	492.67	630.17
Short-Term Investments	11.05	10.7	10.56	11.13	11.59
Cash & Short-Term Investments	764.65	573.86	644.76	503.81	641.76
Cash Growth	33.25%	-11.00%	27.98%	-21.50%	6.60%
Accounts Receivable	1,261	1,226	965.35	865.26	731.26
Other Receivables	50.02	43.12	41.49	116.91	42.8
Receivables	1,311	1,270	1,007	982.17	774.06
Inventory	796.25	655.91	775.84	586.85	509.16
Prepaid Expenses	-	1.84	-	-	-
Other Current Assets	688.95	528.84	384.56	389.53	313.25
Total Current Assets	3,561	3,030	2,812	2,462	2,238
Property, Plant & Equipment	294.57	317.6	328.55	294.08	348.44
Goodwill	6	6	6.02	6.02	6.02
Other Intangible Assets	68.33	72.49	76.72	80.86	143.03
Long-Term Deferred Tax Assets	11.48	7.64	7.38	6.8	8.16
Long-Term Deferred Charges	18.69	22.91	16.98	16.34	19.21
Total Assets	3,960	3,457	3,248	2,866	2,763
Accounts Payable	894.06	826.51	936.49	876.78	809.77
Accrued Expenses	66.98	61.29	58.35	86.48	47.84
Short-Term Debt	1,762	1,350	1,338	1,166	1,193
Current Portion of Long-Term Debt	4.25	1.22	-	-	31.78
Current Portion of Leases	8.97	8.78	6.59	4.15	2.97
Finance Div. Other Current Liabilities	0.23	0.2	-	-	-
Current Income Taxes Payable	14.2	11.72	12.85	27.05	6.41
Current Unearned Revenue	5.02	2.1	19.49	13.53	46.66
Other Current Liabilities	525.65	526.3	247.55	81.98	20.44
Total Current Liabilities	3,281	2,789	2,619	2,256	2,159
Long-Term Debt	38.1	13.8	-	-	86.87
Long-Term Leases	24.21	35.17	30.39	15.75	12.49
Long-Term Unearned Revenue	-	-	-	-	0.3
Long-Term Deferred Tax Liabilities	0.19	0.38	0.6	0.06	0.4
Total Liabilities	3,344	2,838	2,650	2,271	2,259
Common Stock	108	108	108	108	108
Additional Paid-In Capital	278	278	278	278	278
Retained Earnings	229.37	231.7	210.82	208.07	117.11
Comprehensive Income & Other	0.99	0.99	0.99	0.99	0.99
Total Common Equity	616.36	618.69	597.81	595.06	504.1
Shareholders' Equity	616.36	618.69	597.81	595.06	504.1
Total Liabilities & Equity	3,960	3,457	3,248	2,866	2,763
Total Debt	1,837	1,409	1,375	1,186	1,327
Net Cash (Debt)	-1,073	-835.6	-729.76	-681.72	-685.4
Net Cash Per Share	-9.93	-7.74	-6.76	-6.31	-6.35
Filing Date Shares Outstanding	108	108	108	108	108
Total Common Shares Outstanding	108	108	108	108	108
Working Capital	279.79	241.39	193.14	206.77	79.3
Book Value Per Share	5.71	5.73	5.54	5.51	4.67
Tangible Book Value	542.04	540.2	515.06	508.18	355.04
Tangible Book Value Per Share	5.02	5.00	4.77	4.71	3.29
Buildings	298.92	298.21	298.21	269.2	329.71
Machinery	100.01	98.08	81.06	76.69	101.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.